The new deadline, May 16, coincides with the deadline for comments on the FSMA as a whole.
“FDA is taking the action of extending the deadline for the comment period in response to requests for that extension, in order to allow interested persons additional time to submit comments,” an agency media release read.
To read more, click HERE.